Brain renin-angiotensin system and dopaminergic cell vulnerability
about
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseDopamine Receptors and NeurodegenerationBrain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia.Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration.Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells.Laser capture microdissection protocol for gene expression analysis in the brain.Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.Mitochondrial-dependent mechanisms are involved in angiotensin II-induced apoptosis in dopaminergic neurons.Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration.Activation of Autophagy Contributes to the Angiotensin II-Triggered Apoptosis in a Dopaminergic Neuronal Cell Line.Editorial: Parkinson's disease: cell vulnerability and disease progression.Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain-Its Possible Clinical Applications.The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system.Insulin-Like Growth Factor-1 and Neuroinflammation.Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans.Within the Brain: The Renin Angiotensin System.
P2860
Q21131066-7E469D3F-6F2A-4F36-B125-DFE4F0F979D4Q26783348-98841EFE-8E00-4920-B115-31CC037EB265Q33627982-AF6949EC-B88A-45BB-9F1C-DF9D42443668Q33687719-270DE6A2-F8F8-4D5D-9F83-4C3551CC18CEQ36168905-79D29F93-3AF4-49C2-B52C-6A050F00F9B6Q36270869-466AA1CC-98F3-4B86-A6E1-4DADBF9DCC1DQ36385775-17CA2228-38F2-492C-A512-8F892A4C9766Q37327417-20F2E89C-1664-4497-8B4C-9DF15B2FFAA0Q38741492-B66164FB-DD6B-4752-A6AF-FBE2474BD020Q38834345-002FB320-FFC1-4FCE-B36A-DB45B36EA24AQ38883495-AAFCAC10-315B-4164-BD0D-8BBD5FA39112Q41846573-FEE4BBA4-95F4-4FE3-8EFD-8F7953AB0372Q42023331-6256B938-4665-463B-B9FC-2EB95D9A03ECQ42261440-C04F0CD0-4ED8-46D3-B0A1-1318C8CC17C3Q47107877-D11AB9EA-A128-4FC0-A557-374B0451E3B8Q47686009-34F316F8-CEB2-42A1-820B-B924511EE128Q51762826-1809A288-AFD5-4E85-99D1-EFE19A5427CA
P2860
Brain renin-angiotensin system and dopaminergic cell vulnerability
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Brain renin-angiotensin system and dopaminergic cell vulnerability
@ast
Brain renin-angiotensin system and dopaminergic cell vulnerability
@en
type
label
Brain renin-angiotensin system and dopaminergic cell vulnerability
@ast
Brain renin-angiotensin system and dopaminergic cell vulnerability
@en
prefLabel
Brain renin-angiotensin system and dopaminergic cell vulnerability
@ast
Brain renin-angiotensin system and dopaminergic cell vulnerability
@en
P2093
P2860
P356
P1476
Brain renin-angiotensin system and dopaminergic cell vulnerability
@en
P2093
Ana Borrajo
Jose L Labandeira-García
Pablo Garrido-Gil
Rita Valenzuela
P2860
P356
10.3389/FNANA.2014.00067
P577
2014-07-08T00:00:00Z